Table 1.
Patient- and site-level characteristics at ART initiation by tuberculosis treatment status, Côte d’Ivoire, 2004–2008
All patients at enrollment (n = 2110) |
Receiving anti-tuberculosis treatment* (n = 150) | Not receiving anti-tuberculosis treatment* (n = 1960) | ||||
---|---|---|---|---|---|---|
Original‡ |
Imputed* | |||||
n | % | % | % | % | P value† | |
Age at enrollment, years, median [IQR] | 2110 | 5.1 [2.2–8.8] | 5.1 [2.2–8.8] | 6.7 [3.2–10.7] | 5.0 [2.1–3.2] | <0.001 |
Sex | ||||||
Male | 1146 | 54 | 54 | 54 | 54 | 0.952 |
Females | 964 | 46 | 46 | 46 | 46 | |
Maternal vital status | ||||||
Mother alive | 1128 | 67 | 67 | 64 | 68 | 0.510 |
Mother dead | 549 | 33 | 33 | 36 | 32 | |
Missing | 433 | 21 | ||||
Paternal vital status | ||||||
Father alive | 1155 | 77 | 77 | 77 | 77 | 0.964 |
Father dead | 348 | 23 | 23 | 23 | 23 | |
Missing | 607 | 29 | ||||
Type of HIV | ||||||
HIV-1 | 2044 | 99 | 99 | 99 | 99 | 0.553 |
HIV-2 or dual HIV-1 & 2 | 20 | 1 | 1 | 1 | 1 | |
Missing | 46 | 2 | ||||
WHO Stage | ||||||
I/II | 329 | 19 | 19 | 4 | 20 | <0.001 |
III | 939 | 53 | 53 | 24 | 55 | |
IV | 510 | 29 | 29 | 72 | 25 | |
Missing | 332 | 16 | ||||
Weight-for-age Z-score | ||||||
≥ –1 (normal) | 372 | 19 | 20 | 13 | 21 | <0.001 |
≥ −2 — < −1 (mild) | 357 | 19 | 18 | 15 | 19 | |
≥ −3 — < −2 (moderate) | 383 | 20 | 20 | 14 | 20 | |
< −3 (severe) | 798 | 42 | 42 | 59 | 40 | |
Missing | 200 | 9 | ||||
CD4 cell count %, median [IQR] | 1835 | 10.8 [5.4–15.0] | 11.0 [6.0–15.0] | 9.0 [4.0–13.0] | 11.0 [6.0–15.0] | 0.037 |
Missing | 275 | 13 | ||||
CD4 cell count, cells/μl, median [IQR] | 1894 | 333 [116–618] | 337 [122–621] | 261 [78–547] | 342 [126–624] | 0.089 |
Missing | 216 | 10 | ||||
Hemoglobin, g/dl, median [IQR] | 1759 | 9.3 [8.3–10.3] | 9.3 [8.3–10.4] | 9.5 [8.5–10.6] | 9.3 [8.3–10.3] | 0.246 |
Missing | 351 | 17 | ||||
ART site size | ||||||
≥ 100 ART children ever | 1210 | 57 | 57 | 69 | 56 | 0.072 |
< 100 ART children ever | 900 | 43 | 43 | 31 | 44 | |
ART site type | ||||||
Primary | 1181 | 56 | 56 | 43 | 57 | 0.011 |
Secondary | 231 | 11 | 11 | 6 | 11 | |
Tertiary | 698 | 33 | 33 | 51 | 32 | |
Any stock-out of ARVs (first- or second-line) in last year at ART site | ||||||
Yes | 955 | 45 | 45 | 45 | 45 | 0.804 |
No | 1155 | 55 | 55 | 55 | 55 | |
Nutritional support at ART site? | ||||||
Yes | 713 | 34 | 34 | 17 | 35 | 0.007 |
No | 1397 | 66 | 66 | 83 | 65 |
Analyses utilized imputed data sets.
Random effects bivariate logistic regression.
Original data before imputation.
ART = antiretroviral therapy; IQR = interquartile range; HIV = human immunodeficiency virus; WHO = World Health Organization; ARV = antiretroviral.